• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 DNA 编码文库筛选发现新型强效吲唑 NLRP3 抑制剂。

The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening.

机构信息

BioAge Labs, 1445 S. 50(th) St. Richmond, CA 94804, USA.

BioAge Labs, 1445 S. 50(th) St. Richmond, CA 94804, USA.

出版信息

Bioorg Med Chem Lett. 2024 Apr 1;102:129675. doi: 10.1016/j.bmcl.2024.129675. Epub 2024 Feb 28.

DOI:10.1016/j.bmcl.2024.129675
PMID:38417632
Abstract

NLRP3 is an intracellular sensor protein that detects a broad range of danger signals and environmental insults. Its activation results in a protective pro-inflammatory response designed to impair pathogens and repair tissue damage via the formation of the NLRP3 inflammasome. Assembly of the NLRP3 inflammasome leads to caspase 1-dependent secretory release of the pro-inflammatory cytokines IL-1β and IL-18 as well as to gasdermin d-mediated pyroptotic cell death. Herein, we describe the discovery of a novel indazole series of high affinity, reversible inhibitors of NLRP3 activation through screening of DNA-encoded libraries and the potent lead compound 3 (BAL-0028, IC50 = 25 nM) that was identified directly from the screen. SPR studies showed that compound 3 binds tightly (K range 104-123 nM) to the NACHT domain of NLRP3. A CADD analysis of the interaction of compound 3 with the NLRP3 NACHT domain proposes a binding site that is distinct from those of ADP and MCC950 and includes specific site interactions. We anticipate that compound 3 (BAL-0028) and other members of this novel indazole class of neutral inhibitors will demonstrate significantly different physical, biochemical, and biological properties compared to NLRP3 inhibitors previously identified.

摘要

NLRP3 是一种细胞内传感器蛋白,可检测广泛的危险信号和环境损伤。其激活会导致保护性的促炎反应,旨在通过形成 NLRP3 炎性小体来削弱病原体并修复组织损伤。NLRP3 炎性小体的组装导致半胱天冬酶 1 依赖性促炎细胞因子 IL-1β 和 IL-18 的分泌释放,以及气液蛋白 d 介导的细胞焦亡。在此,我们通过 DNA 编码文库筛选描述了一种新型吲唑系列高亲和力、可逆的 NLRP3 激活抑制剂的发现,以及直接从筛选中鉴定出的强效先导化合物 3(BAL-0028,IC50=25 nM)。SPR 研究表明,化合物 3 与 NLRP3 的 NACHT 结构域紧密结合(K 范围为 104-123 nM)。化合物 3 与 NLRP3 NACHT 结构域相互作用的 CADD 分析提出了一个与 ADP 和 MCC950 不同的结合位点,包括特定的位点相互作用。我们预计化合物 3(BAL-0028)和该新型吲唑类中性抑制剂的其他成员将表现出与先前鉴定的 NLRP3 抑制剂明显不同的物理、生化和生物学特性。

相似文献

1
The discovery of novel and potent indazole NLRP3 inhibitors enabled by DNA-encoded library screening.通过 DNA 编码文库筛选发现新型强效吲唑 NLRP3 抑制剂。
Bioorg Med Chem Lett. 2024 Apr 1;102:129675. doi: 10.1016/j.bmcl.2024.129675. Epub 2024 Feb 28.
2
The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.斑马鱼 NLRP3 炎性小体在 ASC 依赖性白细胞介素-1β成熟和 GSDME 介导的细胞焦亡中发挥功能作用。
J Biol Chem. 2020 Jan 24;295(4):1120-1141. doi: 10.1074/jbc.RA119.011751. Epub 2019 Dec 18.
3
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors.发现强效、口服生物利用度的三环 NLRP3 抑制剂。
J Med Chem. 2024 Jan 25;67(2):1544-1562. doi: 10.1021/acs.jmedchem.3c02098. Epub 2024 Jan 4.
4
Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.葡萄糖调控巨噬细胞低氧诱导的 NLRP3 炎性小体激活。
J Cell Physiol. 2020 Oct;235(10):7554-7566. doi: 10.1002/jcp.29659. Epub 2020 Mar 1.
5
Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.富氢盐水通过抑制炎症反应减轻大鼠蛛网膜下腔出血诱导的早期脑损伤:NF-κB通路和NLRP3炎性小体的可能参与
Mol Neurobiol. 2016 Jul;53(5):3462-3476. doi: 10.1007/s12035-015-9242-y. Epub 2015 Jun 20.
6
A small molecule inhibitor of caspase-1 inhibits NLRP3 inflammasome activation and pyroptosis to alleviate gouty inflammation.一种 caspase-1 的小分子抑制剂可抑制 NLRP3 炎性小体激活和细胞焦亡,从而减轻痛风性炎症。
Immunol Lett. 2022 Apr;244:28-39. doi: 10.1016/j.imlet.2022.03.003. Epub 2022 Mar 11.
7
The NLRP3 inflammasome: molecular activation and regulation to therapeutics.NLRP3 炎性小体:分子激活与治疗调控。
Nat Rev Immunol. 2019 Aug;19(8):477-489. doi: 10.1038/s41577-019-0165-0.
8
Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis.一种新型强效 NOD 样受体热蛋白结构域相关蛋白 3(NLRP3)炎症小体抑制剂的药理学研究,该抑制剂可减轻非酒精性脂肪性肝炎和肝纤维化的发展。
J Pharmacol Exp Ther. 2023 Aug;386(2):242-258. doi: 10.1124/jpet.123.001639. Epub 2023 Jun 12.
9
Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.仙台病毒 V 蛋白通过阻止 NLRP3 炎性小体组装来抑制白细胞介素-1β的分泌。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00842-18. Print 2018 Oct 1.
10
1'-Acetoxychavicol acetate inhibits NLRP3-dependent inflammasome activation via mitochondrial ROS suppression.1'-乙酰氧基胡椒酚乙酸酯通过抑制线粒体 ROS 抑制 NLRP3 依赖的炎性体激活。
Int Immunol. 2021 Jun 18;33(7):373-386. doi: 10.1093/intimm/dxab016.

引用本文的文献

1
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action.发现具有新型作用机制的强效且选择性的人NLRP3抑制剂。
J Exp Med. 2025 Nov 3;222(11). doi: 10.1084/jem.20242403. Epub 2025 Sep 2.
2
The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets.NLRP3炎性小体从周期性发热到治疗靶点的作用扩展
Nat Immunol. 2025 Aug 18. doi: 10.1038/s41590-025-02230-7.
3
From Lab to Clinic: How Artificial Intelligence (AI) Is Reshaping Drug Discovery Timelines and Industry Outcomes.
从实验室到临床:人工智能如何重塑药物研发时间表和行业成果。
Pharmaceuticals (Basel). 2025 Jun 30;18(7):981. doi: 10.3390/ph18070981.
4
Effects of acute pro-inflammatory stimulation and 25-hydroxycholesterol on hippocampal plasticity and learning involve NLRP3 inflammasome and cellular stress responses.急性促炎刺激和25-羟基胆固醇对海马可塑性和学习的影响涉及NLRP3炎性小体和细胞应激反应。
Sci Rep. 2025 Feb 20;15(1):6149. doi: 10.1038/s41598-025-90149-2.